These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8971894

  • 1. Risk factors for relapse in childhood nephrotic syndrome.
    Takeda A, Matsutani H, Niimura F, Ohgushi H.
    Pediatr Nephrol; 1996 Dec; 10(6):740-1. PubMed ID: 8971894
    [Abstract] [Full Text] [Related]

  • 2. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
    Raja K, Parikh A, Webb H, Hothi D.
    Pediatr Nephrol; 2017 Jan; 32(1):99-105. PubMed ID: 27677978
    [Abstract] [Full Text] [Related]

  • 3. A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children.
    Hiraoka M, Tsukahara H, Matsubara K, Tsurusawa M, Takeda N, Haruki S, Hayashi S, Ohta K, Momoi T, Ohshima Y, Suganuma N, Mayumi M, West Japan Cooperative Study Group of Kidney Disease in Children.
    Am J Kidney Dis; 2003 Jun; 41(6):1155-62. PubMed ID: 12776266
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of low birth weight and prematurity with clinical outcomes of childhood nephrotic syndrome: a prospective cohort study.
    Konstantelos N, Banh T, Patel V, Vasilevska-Ristovska J, Borges K, Hussain-Shamsy N, Noone D, Hebert D, Radhakrishnan S, Licht CPB, Langlois V, Pearl RJ, Parekh RS.
    Pediatr Nephrol; 2019 Sep; 34(9):1599-1605. PubMed ID: 30976899
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM, Knight JF, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2001 Sep; (2):CD001533. PubMed ID: 11405997
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.
    Ekka BK, Bagga A, Srivastava RN.
    Pediatr Nephrol; 1997 Oct; 11(5):597-9. PubMed ID: 9323286
    [Abstract] [Full Text] [Related]

  • 11. High incidence of initial and late steroid resistance in childhood nephrotic syndrome.
    Kim JS, Bellew CA, Silverstein DM, Aviles DH, Boineau FG, Vehaskari VM.
    Kidney Int; 2005 Sep; 68(3):1275-81. PubMed ID: 16105061
    [Abstract] [Full Text] [Related]

  • 12. Persistent hypercholesterolaemia in frequently relapsing steroid-responsive nephrotic syndrome.
    Tsukahara H, Haruki S, Hiraoka M, Hori C, Sudo M.
    J Paediatr Child Health; 1997 Jun; 33(3):253-5. PubMed ID: 9259304
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
    Skrzypczyk P, Panczyk-Tomaszewska M, Roszkowska-Blaim M, Wawer Z, Bienias B, Zajgzkowska M, Kilis-Pstrusinska K, Jakubowska A, Szczepaniak M, Pawlak-Bratkowska M, Tkaczyk M.
    Clin Nephrol; 2014 Mar; 81(3):166-73. PubMed ID: 24361057
    [Abstract] [Full Text] [Related]

  • 14. Reciprocal Regulation of 11β-HSDs May Predict Steroid Sensitivity in Childhood Nephrotic Syndrome.
    Sai S, Yamamoto M, Yamaguchi R, Chapman KE, Hongo T.
    Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27507896
    [Abstract] [Full Text] [Related]

  • 15. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
    Fujinaga S, Hirano D, Mizutani A, Sakuraya K, Yamada A, Sakurai S, Shimizu T.
    Clin Exp Nephrol; 2017 Aug; 21(4):671-676. PubMed ID: 27558467
    [Abstract] [Full Text] [Related]

  • 16. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [Abstract] [Full Text] [Related]

  • 17. Comparative study of prednisolone alone and prednisolone plus fusidic acid in the treatment of children with steroid-responsive nephrotic syndrome.
    Cerkauskiene R, Kaltenis P.
    Medicina (Kaunas); 2005 Mar; 41 Suppl 1():26-30. PubMed ID: 15901972
    [Abstract] [Full Text] [Related]

  • 18. [Influence of omega-3 fatty acids on lipid metabolism in children with steroid sensitive nephrotic syndrome].
    Cerkauskiene R, Kaminskas A, Kaltenis P, Vitkus D.
    Medicina (Kaunas); 2003 Mar; 39 Suppl 1():82-7. PubMed ID: 12761426
    [Abstract] [Full Text] [Related]

  • 19. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
    Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
    [Abstract] [Full Text] [Related]

  • 20. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
    Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
    BMC Nephrol; 2018 Sep 10; 19(1):223. PubMed ID: 30200895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.